Investment Objective
The investment seeks to track the performance of a benchmark index that measures the investment return of stocks issued by companies located in developed and emerging markets, excluding the United States.
The fund employs an indexing investment approach designed to track the performance of the FTSE Global All Cap ex US Index, a free-float-adjusted market-capitalization-weighted index designed to measure equity market performance of companies located in developed and emerging markets, excluding the United States. The index includes more than 5,330 stocks of companies located in 45 countries.
Latest VXUS News
Performance
| 1 month | +3.73% | | 3 years | +4.29% |
| 3 months | +3.01% | | 5 years | -- |
| 1 year | +11.76% | | Since inception | +4.50% |
Quote Details
| Previous close | $52.39 |
| Open day’s range | 51.73 – 52.16 |
| Net asset value (NAV) | 52.32 (03/07/2014) |
| Daily volume | 334,020 |
| Average volume (3 months) | 271,587 |
Data as of 3:59pm ET, 03/10/2014
Peer Comparisonvs. Foreign large blend ETFs
| | VXUS | Category |
|---|
| Performance 5-yr return | -- | +11.97% |
| Expense Gross exp ratio | 0.14% | 0.43% |
| Risk 5 year sharpe ratio | -- | 0.93 |
| Net assets | $118.2B | $4.4B |
| Average market cap | $21.4B | $37.2B |
| Average P/E | 14.4 | 15.2 |
| Dividend / Share | -- | 0.46% |
Competitors
| SCHF Schwab International Equity ETF |
| VEA Vanguard FTSE Developed Markets ETF |
| ACWX iShares MSCI ACWI ex U.S. ETF |
Holdings
Top 5 Sectors
Portfolio weighting
Top 10 Holdings
Portfolio weighting
| -- Nestle SA | 1.16% |
| -- Roche Holding AG | 0.96% |
| -- HSBC Holdings PLC | 0.96% |
| -- Novartis AG | 0.91% |
| -- Vodafone Group PLC | 0.90% |
| -- Toyota Motor Corp | 0.75% |
| -- BP PLC | 0.73% |
| -- Royal Dutch Shell PLC Class A | 0.66% |
| -- GlaxoSmithKline PLC | 0.62% |
| -- Total SA | 0.58% |
-0.37 / -0.71%
.
